Healthcare provider profile · identity verified

Scott A Johnson, D.O.

Family Practice · WYOMING, MI · NPI 1396709648

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	736	243
Amlodipine Besylate	Amlodipine Besylate	477	148
Lisinopril	Lisinopril	413	125
Omeprazole	Omeprazole	385	102
Levothyroxine Sodium	Levothyroxine Sodium	319	87
Losartan Potassium	Losartan Potassium	290	90
Metformin Hcl Er	Metformin Hcl	237	71
Gabapentin	Gabapentin	233	53
Trazodone Hcl	Trazodone Hcl	208	43
Metformin Hcl	Metformin Hcl	204	66
Tamsulosin Hcl	Tamsulosin Hcl	191	59
Albuterol Sulfate Hfa	Albuterol Sulfate	176	57
Pantoprazole Sodium	Pantoprazole Sodium	151	52
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	147	31
Metoprolol Succinate	Metoprolol Succinate	138	44
Allopurinol	Allopurinol	132	36
Sertraline Hcl	Sertraline Hcl	128	47
Duloxetine Hcl	Duloxetine Hcl	126	29
Rosuvastatin Calcium	Rosuvastatin Calcium	105	39
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	97	31
Hydrochlorothiazide	Hydrochlorothiazide	92	33
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	92	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	81	22
Carvedilol	Carvedilol	79	19
Pioglitazone Hcl	Pioglitazone Hcl	79	24
Tramadol Hcl	Tramadol Hcl	78	18
Trulicity	Dulaglutide	73	16
Meloxicam	Meloxicam	71	30
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	69	23
Fluticasone Propionate	Fluticasone Propionate	67	23
Jardiance	Empagliflozin	67	18
Bupropion Xl	Bupropion Hcl	64	18
Farxiga	Dapagliflozin Propanediol	63	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	63	20
Pravastatin Sodium	Pravastatin Sodium	62	18
Simvastatin	Simvastatin	61	16
Potassium Chloride	Potassium Chloride	60	21
Clopidogrel	Clopidogrel Bisulfate	57	17
Glipizide Er	Glipizide	57	18
Hydroxyzine Hcl	Hydroxyzine Hcl	55	13
Prednisone	Prednisone	53	37
Citalopram Hbr	Citalopram Hydrobromide	50	14
Lovastatin	Lovastatin	50	11
Tizanidine Hcl	Tizanidine Hcl	50	15
Fluoxetine Hcl	Fluoxetine Hcl	47	14
Metoprolol Tartrate	Metoprolol Tartrate	45	16
Escitalopram Oxalate	Escitalopram Oxalate	44	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	19
Ozempic	Semaglutide	44	15
Eliquis	Apixaban	41	15
Ipratropium Bromide	Ipratropium Bromide	41	20
Venlafaxine Hcl Er	Venlafaxine Hcl	41	suppressed
Benazepril Hcl	Benazepril Hcl	39	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	39	16
Pregabalin	Pregabalin	39	suppressed
Alprazolam	Alprazolam	37	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	36	14
Doxazosin Mesylate	Doxazosin Mesylate	36	suppressed
Furosemide	Furosemide	36	18
Famotidine	Famotidine	35	17
Diazepam	Diazepam	34	suppressed
Methocarbamol	Methocarbamol	34	13
Mirtazapine	Mirtazapine	34	suppressed
Bupropion Hcl Sr	Bupropion Hcl	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	14
Doxycycline Hyclate	Doxycycline Hyclate	32	19
Baclofen	Baclofen	31	suppressed
Humalog Kwikpen U-100	Insulin Lispro	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Mupirocin	Mupirocin	28	19
Januvia	Sitagliptin Phosphate	27	suppressed
Montelukast Sodium	Montelukast Sodium	27	suppressed
Clonazepam	Clonazepam	26	suppressed
Ezetimibe	Ezetimibe	26	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Mounjaro	Tirzepatide	25	suppressed
Finasteride	Finasteride	24	suppressed
Glimepiride	Glimepiride	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	23	13
Doxepin Hcl	Doxepin Hcl	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	22	suppressed
Cephalexin	Cephalexin	22	20
Lantus	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Spiriva Respimat	Tiotropium Bromide	22	suppressed
Azithromycin	Azithromycin	21	20
Triamcinolone Acetonide	Triamcinolone Acetonide	21	14
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	21	suppressed
Azelastine Hcl	Azelastine Hcl	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	19
Ondansetron Hcl	Ondansetron Hcl	20	14
Fenofibrate	Fenofibrate	19	suppressed
Humalog	Insulin Lispro	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Glycopyrrolate	Glycopyrrolate	18	suppressed
Linzess	Linaclotide	18	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	18	suppressed
Atenolol	Atenolol	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	16	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Colchicine	Colchicine	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	15	suppressed
Amoxicillin	Amoxicillin	14	13
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Alendronate Sodium	Alendronate Sodium	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error